<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM/DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd"><?xml-stylesheet type="text/xsl" href="ViewNLM-v2.3.xsl"?><article xml:lang="EN" article-type="research-article">
	<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
<journal-id journal-id-type="publisher-id">JKMS</journal-id>
<journal-title>Journal of Korean Medical Science</journal-title>
<issn pub-type="ppub">1011-8934</issn>
<issn pub-type="epub">1598-6357</issn>
<publisher>
<publisher-name>The Korean Academy of Medical Sciences</publisher-name>
</publisher>
</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.3346/jkms.2001.16.4.439</article-id>
			<article-categories>
				<subj-group>
					<subject>Original Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Parenchymal and Nonparenchymal Cellular Responses in Human Hepatic Regeneration</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Yoon</surname>
						<given-names>Ghil Suk</given-names>
					</name>
					<xref ref-type="aff" rid="A1"></xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Suriawinata</surname>
						<given-names>Arief</given-names>
					</name>
					<xref ref-type="aff" rid="A2">&#x002A;</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Thung</surname>
						<given-names>Swan N</given-names>
					</name>
					<xref ref-type="aff" rid="A2">&#x002A;</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Yu</surname>
						<given-names>Eunsil</given-names>
					</name>
					<xref ref-type="aff" rid="A2">&#x002A;</xref>
				</contrib>
			</contrib-group>
				<aff id="A1">Departments of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.</aff>
				<aff id="A2"><label>&#x002A;</label>The Mount Sinai Medical Center, New York, U.S.A.</aff>
				<author-notes>
					<corresp>
						<email>esyu@www.amc.seoul.kr</email>
					</corresp>
				</author-notes>
			<pub-date pub-type="ppub">
				<month>08</month>
				<year>2001</year>
			</pub-date>
			<pub-date pub-type="epub">
				<day>24</day>
				<month>04</month>
				<year>2009</year>
			</pub-date>
			<volume>16</volume>
			<issue>4</issue>
			<fpage>439</fpage>
			<lpage>447</lpage>
			<permissions>
				<copyright-statement>Copyright &#x00A9; 2001 The Korean Academy of Medical Sciences</copyright-statement>
				<copyright-year>2001</copyright-year>
			</permissions>
			<abstract>
				<p>To characterize cellular responses during hepatic regeneration, we examined 13 explant livers and 5 liver allografts by immunohistochemistry for cytokeratin 7, HepPar1, CD68, &#x03B1;-smooth muscle actin (&#x03B1;-SMA) and proliferating cell nuclear antigen as well as reticulin and Masson-trichrome staining. Within a week after liver damage, elongated CD68-positive cells were detected along the border of necrotic area. The number of &#x03B1;-SMA-positive cells was slightly increased along the sinusoids. Ductular proliferation or fibrosis was negligible. After one or two weeks, the size and number of CD68-positive cells were markedly increased.&#x03B1;-SMA-positive cells increased in number within lobules and portal tracts. Ductular proliferation occurred predominantly at the limiting plate or along the border of necrotic areas. After one month, necrotic parenchyma was replaced by many ductules, CD68-positive cells, &#x03B1;-SMA-positive cells. Nodules of regenerating hepatocytes and irregular fibrosis were diffusely present. Other nonparenchymal cells were not significantly changed. These observations indicate that chronological interaction between nonparenchymal and parenchymal cells occur during the course of human hepatic regeneration and suggest extensive porto-periportal fibrosis more than a few months after the onset of fulminant hepatitis is a major indicator of chronic functional impairment necessitating liver transplantation.</p>
		</abstract>
		<kwd-group>
			<kwd>Liver Failure</kwd>
			<kwd>Hepatitis</kwd>
			<kwd>Liver Regeneration</kwd>
			<kwd>Kupffer Cells</kwd>
			<kwd>Hepatic Stellate Cell</kwd>
			<kwd>Hepatic Stem Cells</kwd>
			<kwd>Bile Ducts</kwd>
			<kwd>Epithelium</kwd>
			</kwd-group>

		</article-meta>
</front>
</article>


 

